Rongrong Cui

capital medical university

H指数:29

被引数:2,321

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design, synthesis, and structure-activity relationship studies of triazolo-pyrimidine derivatives as WRN inhibitors for the treatment of MSI tumors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2025-01-011

PRE

Challenges in the diagnosis of fibrodysplasia ossificans progressiva with the ACVR1 mutation (c.774G > C, p.R258S): a case report and review of literature

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2024-09-300

OAAI

Case report: Thyroid metastasis from hepatocellular carcinoma: a rare case with diffuse solid occupancy and unusual imaging findings

FRONTIERS IN ONCOLOGY

IF3.3

2024-07-100

OAAI

Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis in Patients With Type 2 Diabetes Using Quantitative Perfusion MRI

JOURNAL OF MAGNETIC RESONANCE IMAGING

IF3.5

2024-02-205

OAAI

Targeting JMJD1C to selectively disrupt tumor Treg cell fitness enhances antitumor immunity

NATURE IMMUNOLOGY

IF27.6

2024-02-1412

PRE

Transfer learning enhanced graph neural network for aldehyde oxidase metabolism prediction and its experimental application

醛氧化酶代谢预测的迁移学习增强图神经网络及其实验应用

ACTA PHARMACEUTICA SINICA B

IF14.6

2024-02-011

OAAI

Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRASG12D

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-01-107

PRE

Endovascular Thrombectomy for a Progressive Stroke Patient With a High-Burden Carotid Free-Floating Thrombus

ANNALS OF NEUROLOGY

IF7.7

2023-10-271

PRE

Endovascular treatment versus standard medical treatment for basilar artery occlusion: a meta-analysis of randomized controlled trials

JOURNAL OF NEUROSURGERY

IF3.6

2023-09-0110

PRE

Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebocontrolled, dose-escalation phase 1 trial

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-04-053

OAAI

Discovery of a Potent, Cooperative, and Selective SOS1 PROTAC ZZ151 with In Vivo Antitumor Efficacy in KRAS-Mutant Cancers

在KRAS突变癌症中发现具有体内抗肿瘤功效的有效，合作和选择性SOS1 PROTAC ZZ151

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-03-1021

PRE

Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway

二肽基Peptidase-4通过激活转化生长因子 β 信号通路稳定整合素 α4β1复合物促进甲状腺癌细胞转移

THYROID

IF6.7

2022-11-0116

PRE

Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations

首次发现基于激动剂的SOS1 PROTACs在携带各种KRAS突变的人类癌细胞中有效

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2022-03-0150

PRE

Discovery of Pyrazolo[3,4-d]pyridazinone Derivatives as Selective DDR1 Inhibitors via Deep Learning Based Design, Synthesis, and Biological Evaluation

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2021-11-2537

PREAI

Active Learning for Drug Design: A Case Study on the Plasma Exposure of Orally Administered Drugs

药物设计的主动学习: 口服药物血浆暴露的案例研究

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2021-11-1519

PREAI

Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors

吡唑并 [3，4-d] 哒嗪酮共价FGFR抑制剂的设计、合成及生物活性评价

ACTA PHARMACEUTICA SINICA B

IF14.6

2021-03-0119

OAAI

Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers

Sp1和GABPA协同激活突变TERT启动子在BRAFV600E-driven人类癌症中的作用

NPJ PRECISION ONCOLOGY

IF8

2021-01-228

OAAI

Clinical Characterization of Mismatch Repair Gene-Deficient Metastatic Castration-Resistant Prostate Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2020-10-078

OAAI

Revisiting Aldehyde Oxidase Mediated Metabolism in Drug-like Molecules: An Improved Computational Model

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-03-1910

PREAI

Exosomes increased angiogenesis in papillary thyroid cancer microenvironment (vol 26, pg 525, 2019)

ENDOCRINE-RELATED CANCER

IF4.6

2020-03-011

Rongrong Cui

个人简介

教育背景

工作经历

荣誉奖项

研究方向